세계의 바이오테크놀러지 시장 규모, 점유율, 성장 분석 : 제품 유형별, 기술별, 용도별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)

Biotechnology Market size was valued at USD 2.12 trillion in 2023 and is poised to grow from USD 2.39 trillion in 2024 to USD 6.26 trillion by 2032, growing at a CAGR of 12.79% during the forecast period (2025-2032).

The biotech industry is a highly globalized sector experiencing diverse economic growth across nations. Rising health issues, particularly hepatitis B and chronic diseases like diabetes and cancer, are anticipated to drive demand for biotech solutions. The increasing populations in major countries such as the US, China, and India will also heighten the need for agricultural products, including wheat, rice, and sugarcane. Concurrently, scientists are actively engaged in R&D to mitigate challenges such as water scarcity, low crop yield, and pest threats, focusing on smart agricultural systems. Collaborative efforts with both governmental and independent entities are boosting funding for research and development, fostering innovations in biotechnology. Consequently, companies in this field are poised for significant opportunities, particularly those dedicated to developing effective treatments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biotechnology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biotechnology Market Segments Analysis

Global Biotechnology Market is segmented by Product Type, Technology, Application, End User and region. Based on Product Type, the market is segmented into Instruments, Reagents, Services and Software. Based on Technology, the market is segmented into Nano Biotechnology, PCR Technology,DNA sequencing, Chromatography, Tissue Engineering and Regeneration, Cell-Based Assays, Fermentation and Others. Based on Application, the market is segmented into Bio-pharmacy, Bio-industrial, Bio-services, Bioinformatics and Bio-agriculture. Based on End User, the market is segmented into Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biotechnology Market

The global biotechnology market is being significantly driven by the rising incidence of chronic diseases, including cancer and diabetes. As the prevalence of these health issues escalates worldwide, there is a correspondingly growing demand for effective treatments. This urgent need for innovative therapeutic solutions is propelling the expansion of the biotechnology sector on a global scale. The increasing focus on research and development in biotechnology to address these pressing health concerns is further enhancing market growth. As a result, the biotechnology industry is poised for continuous advancement and investment, driven by the imperative to combat chronic illnesses effectively.

Restraints in the Biotechnology Market

The biotechnology sector is heavily reliant on innovation, and when one company secures a patent by being the first to develop a new technology, it can create significant delays for competing firms seeking to bring similar products to market. This situation arises because competitors are unable to use patented methods without facing legal challenges, leading to potential conflicts over intellectual property rights. Such patent-related issues and overlaps can act as considerable barriers to market growth, as they restrict the ability of other companies to leverage similar technologies and diminish their competitive edge in bringing innovative solutions to consumers.

Market Trends of the Biotechnology Market

The biotechnology market is witnessing a significant trend towards synthetic biology, a rapidly growing segment poised to revolutionize various industries including pharmaceuticals, agriculture, and biofuels. This innovative approach enables companies to design and engineer biological systems for diverse applications, enhancing efficiency and sustainability. As the demand for eco-friendly solutions escalates, biotechnology firms are increasingly investing in synthetic biology to develop novel products and processes that address global challenges such as climate change and health crises. By leveraging advances in genetic engineering and computational biology, these companies are not only maximizing revenue opportunities but also positioning themselves as leaders in the future of biotechnological advancements.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Biotechnology Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents
• Services
• Software

Global Biotechnology Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Nano Biotechnology
• PCR Technology
• DNA Sequencing
• Chromatography
• Tissue Engineering and Regeneration
• Cell-Based Assays
• Fermentation
• Others

Global Biotechnology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Bio-pharmacy
• Bio-industrial
• Bio-services
• Bioinformatics
• Bio-agriculture

Global Biotechnology Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Academic and Research Institutes
• Others

Global Biotechnology Market Size & CAGR (2025-2032)

• North America (Product Type, Technology, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Amgen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech (Roche) (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vertex Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novozymes (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC (UK/Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations